KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) CEO Mark T. Iwicki sold 7,392 shares of the firm’s stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $6.09, for a total transaction of $45,017.28. Following the sale, the chief executive officer now directly owns 278,923 shares in […]